Healthier Choices v. Philip Morris: Federal Circuit Affirms Electronic Pipe Patent Cancellation
Healthier Choices Management Corp. challenged a PTAB ruling that cancelled its electronic pipe patent US10561170B2 in an appeal against Philip Morris Products, SA. After 639 days before the Federal Circuit, the court affirmed the Board’s unpatentability findings, leaving the patent invalidated and Philip Morris’s freedom to operate intact.
Federal Circuit closes the door on Healthier Choices’ electronic pipe patent
Healthier Choices Management Corp., a Florida-based health and wellness company, asserted US10561170B2 — a patent covering an electronic pipe device — in proceedings before the Patent Trial and Appeal Board. Philip Morris Products, SA, the Swiss-based subsidiary of Philip Morris International, petitioned for inter partes review, arguing the claims were unpatentable over prior art. The PTAB sided with Philip Morris, cancelling the patent’s claims on unpatentability grounds, and Healthier Choices appealed to the Federal Circuit under Case No. 23-1529, filed February 22, 2023.
The Federal Circuit issued its decision on November 22, 2024, affirming the PTAB’s findings in full. The court expressly reviewed whether substantial evidence supported the Board’s factual determinations and concluded it did, dismissing all of Healthier Choices’ remaining arguments as unpersuasive. An affirmance at this level means the PTAB’s cancellation of US10561170B2 stands as a final judgment, with no further avenue of appeal remaining within the federal court system short of a certiorari petition to the Supreme Court.
The 639-day appellate timeline suggests a fully briefed merits dispute with no early procedural resolution, consistent with contested PTAB appeal practice at the Federal Circuit. The substantial evidence standard applied — deferential to Board fact-finding — likely made reversal difficult once the PTAB had made detailed unpatentability findings. The public record does not disclose whether any parallel district court infringement actions were filed or whether a licensing dispute underpinned the original IPR petition.
Filing to Unpatentable in 639 days
639 days at the Federal Circuit — longer than the median PTAB appeal disposition
Federal Circuit affirms: what the ruling means for both parties
Affirmance means the PTAB cancellation is now final
When the Federal Circuit affirms a PTAB decision, it confirms that the Board committed no reversible error — legally or factually. The appellate panel applied the substantial evidence standard to the Board’s factual findings, meaning the cancellation of US10561170B2 survives scrutiny. The patent’s claims are cancelled and cannot be enforced. The only remaining avenue is a certiorari petition to the U.S. Supreme Court, which is rarely granted in patent cases.
No reversible error foundHealthier Choices loses its electronic pipe patent permanently
For Healthier Choices, affirmance extinguishes US10561170B2 as an enforceable asset. The company cannot assert cancelled claims against Philip Morris or any other competitor. Any licensing programme or litigation strategy built around this patent is effectively foreclosed. Healthier Choices would need to pursue continuation applications or separately filed patents to rebuild protection in the electronic pipe space, though prior art findings at the PTAB may constrain claim scope.
Patent cancelled — unenforceablePhilip Morris secures cleared freedom to operate in this claim space
Philip Morris Products, SA prevails comprehensively: the patent is cancelled, the PTAB decision is affirmed, and Healthier Choices’ appellate arguments were unanimously rejected. Philip Morris and its licensees can operate without risk of infringement claims under US10561170B2. The ruling also raises the bar for any future Healthier Choices effort to revive similar claims, given the prior art record established during IPR proceedings.
Freedom to operate confirmedElectronic pipe IP landscape shifts in favour of incumbents
This affirmance signals that at least some early electronic pipe patent claims face significant prior art exposure when challenged at the PTAB by well-resourced defendants. For competitors and product developers in the heated tobacco and e-pipe sector, the ruling suggests that US10561170B2’s claim scope was not novel or non-obvious over prior art. Companies holding similar early-filing electronic device patents should audit claim strength proactively, and R&D teams should monitor continuation filings from Healthier Choices.
Prior art bar raised in e-pipe IPFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Healthier Choices Management, Corp. | Company | Health and wellness retailer — holder of US10561170B2 (electronic pipe)Search in Eureka ↗ |
| Defendant | Philip Morris Products, SA | Company | Philip Morris Products, SA — multinational tobacco and nicotine products manufacturerSearch in Eureka ↗ |
| Plaintiff counsel | Barry P. Golob | Attorney | Counsel for Healthier Choices Management, Corp.Search in Eureka ↗ |
| Plaintiff counsel | Thomas Fisher | Attorney | Counsel for Healthier Choices Management, Corp.Search in Eureka ↗ |
| Plaintiff law firm | Cozen O’connor, PC | Law Firm | Representing Healthier Choices Management, Corp.Search in Eureka ↗ |
| Defendant counsel | David Zucker | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Defendant counsel | Gabriel K. Bell | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Defendant counsel | Maximilian A. Grant | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Defendant counsel | Richard Gregory Frenkel | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Defendant law firm | Latham & Watkins, LLP | Law Firm | Representing Philip Morris Products, SASearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s language — ‘substantial evidence supports the Board’s findings’ and dismissal of remaining arguments as ‘unpersuasive’ — is a comprehensive merits affirmance, not a procedural one. The substantial evidence standard is deferential: the court need only confirm the Board’s findings are supported by such relevant evidence as a reasonable mind might accept. The panel’s express consideration and rejection of all of Healthier Choices’ arguments leaves no viable ground for further challenge within the federal appellate system. For Philip Morris, the ruling provides the strongest available form of patent clearance short of a district court invalidity judgment.
US10561170B2 — Electronic pipe device technology
US10561170B2, filed under application number US15/923848, protects an electronic pipe — a device category at the intersection of traditional pipe-form factor design and modern electronic vaporisation or heat-not-burn technology. The patent falls within the rapidly evolving heated tobacco and e-nicotine device domain, which has attracted significant IP activity as traditional tobacco companies and new entrants race to establish enforceable positions. The PTAB’s cancellation, affirmed by the Federal Circuit, indicates the claimed invention was found to lack novelty or non-obviousness over identified prior art in the electronic smoking device space.
For the sector, US10561170B2 represented an attempt by a health-oriented retailer to stake out IP in electronic pipe hardware — a category where Philip Morris and other large manufacturers hold extensive portfolios. The cancellation removes one potential licensing or litigation threat from the landscape. However, the prior art findings established during IPR proceedings may now constrain the claim scope available to any party — including Philip Morris competitors — seeking to patent similar electronic pipe configurations. Companies developing products in the e-pipe and personal vaporiser category should treat this IPR record as a key freedom-to-operate reference.
Should your R&D team run an FTO against US10561170B2 and related e-pipe patents?
Product and IP teams developing electronic pipe devices, personal vaporisers, or heat-not-burn hardware should note that US10561170B2 is now cancelled and poses no direct infringement risk. However, Healthier Choices may hold continuation or related family patents that survived or were filed after the IPR. Any team commercialising products in this device category should conduct a full FTO covering the broader Healthier Choices patent family and the prior art landscape established in the IPR record.
PatSnap Eureka’s FTO Search Agent can map the Healthier Choices patent family, identify live continuation applications, and cross-reference the prior art cited in the PTAB proceedings. For Philip Morris competitors entering the electronic pipe space, Eureka’s claim-level analysis surfaces which claim configurations remain contested — helping R&D teams design around active risks rather than cancelled ones.
Run a freedom-to-operate analysis on US10561170B2 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit PTAB appeals in electronic nicotine device patent disputes
Cases involving Federal Circuit review of PTAB unpatentability rulings in the electronic nicotine, e-cigarette, and heated tobacco device sector.
What this case signals for the electronic pipe and heated tobacco IP landscape
A major tobacco group successfully cancelled a competitor’s electronic pipe patent at the PTAB and withstood Federal Circuit review. Here is what that means.
PTAB remains a high-value weapon for large tobacco defendants facing niche patent holders
Philip Morris’s success at both the PTAB and Federal Circuit demonstrates that inter partes review — backed by rigorous prior art search — is an effective and final mechanism for clearing patent obstacles in the e-cigarette and electronic pipe space. Smaller patent holders face an asymmetric cost burden defending PTAB validity challenges all the way to the Federal Circuit.
Substantial evidence deference makes Federal Circuit reversal of PTAB fact-findings rare
The Federal Circuit’s application of the substantial evidence standard means that once the PTAB makes detailed unpatentability findings, appellants face a steep climb. Patent owners appealing adverse IPR decisions should evaluate whether the Board’s factual record truly contains legal error — not just unfavourable fact-finding — before committing to appellate costs exceeding $1M.
Healthier v Philip — key questions answered
The Federal Circuit affirmed the PTAB’s ruling that US10561170B2 — Healthier Choices’ electronic pipe patent — was unpatentable. The decision, issued November 22, 2024, confirmed that substantial evidence supported the Board’s invalidity findings, and dismissed all of Healthier Choices’ appellate arguments as unpersuasive.
An affirmance means the appellate court found no reversible legal or factual error in the PTAB’s decision. Under the substantial evidence standard, the Board’s findings are upheld if supported by evidence a reasonable person could accept. Practically, the patent’s claims are permanently cancelled and unenforceable, with no further appeal available except a certiorari petition to the Supreme Court.
US10561170B2 is a U.S. patent held by Healthier Choices Management Corp. covering an electronic pipe device — a product in the broader electronic nicotine delivery and personal vaporiser category. Filed under application number US15/923848, the patent was challenged by Philip Morris Products via inter partes review and ultimately cancelled by the PTAB, a result the Federal Circuit affirmed.
Based on the public record, US10561170B2 has been cancelled and is unenforceable. Healthier Choices could potentially assert separately filed or continuation patents outside the scope of this IPR proceeding. However, the prior art findings established during IPR may limit available claim scope in any related applications. The public record does not disclose other active patents or pending litigation between these parties.
The substantial evidence standard applies when a federal appellate court reviews factual findings made by an administrative agency — here the PTAB. It requires the reviewing court to uphold findings that are supported by such relevant evidence as a reasonable mind might accept. This deferential standard makes reversal of PTAB unpatentability determinations difficult when the Board has made detailed prior art findings, which is consistent with the outcome in this case.
PatSnap Eureka searches patents and litigation data to answer instantly.